Helene Sou is a Director in Global Regulatory Policy and Innovation, focused on the Growth and Emerging Markets region in Takeda and currently based in Singapore.

Helene has 19 years of experience in international regulatory affairs gained through country, regional and global regulatory roles.

In the early part of her career, Helene worked several years as an EU Regulatory Consultant at Voisin Consulting Life Sciences in Paris, France before shifting to International Regulatory Affairs roles in Boston, USA. In Shire Pharmaceuticals, Helene was the Asia-Pacific Regional Regulatory Lead and Regulatory Head of Southeast Asia. In Takeda, Helene was the Global Regulatory Lead for plasma-derived therapies, then acted as the Regulatory Liaison for the Emerging Markets.

Currently, she is an active member of the Global Regulatory Policy Network (formerly APEC Rare Disease Network), APAC Digital health Data Consortium, APAC RA-EWG, EFPIA-ASEAN and Korea-Taiwan network.

Helene holds a Master of Sciences degree in Biotechnology and Management from the ESIEE-Management school in Paris.